MX2019001859A - Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos. - Google Patents

Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos.

Info

Publication number
MX2019001859A
MX2019001859A MX2019001859A MX2019001859A MX2019001859A MX 2019001859 A MX2019001859 A MX 2019001859A MX 2019001859 A MX2019001859 A MX 2019001859A MX 2019001859 A MX2019001859 A MX 2019001859A MX 2019001859 A MX2019001859 A MX 2019001859A
Authority
MX
Mexico
Prior art keywords
processing
methods
therapeutic protein
recombinant therapeutic
fluid including
Prior art date
Application number
MX2019001859A
Other languages
English (en)
Spanish (es)
Inventor
Warikoo Veena
Konstantinov Konstantin
Vetter Tarl
Coolbaugh Michael
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2019001859A publication Critical patent/MX2019001859A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration
    • B01D61/146Ultrafiltration comprising multiple ultrafiltration steps
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/58Multistep processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/06Submerged-type; Immersion type
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/16Diafiltration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
MX2019001859A 2016-08-16 2017-08-15 Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos. MX2019001859A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662375689P 2016-08-16 2016-08-16
PCT/US2017/046930 WO2018035116A1 (en) 2016-08-16 2017-08-15 Methods of processing a fluid including a recombinant therapeutic protein and use thereof

Publications (1)

Publication Number Publication Date
MX2019001859A true MX2019001859A (es) 2019-08-29

Family

ID=59799450

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019001859A MX2019001859A (es) 2016-08-16 2017-08-15 Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos.
MX2021015165A MX2021015165A (es) 2016-08-16 2019-02-14 Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021015165A MX2021015165A (es) 2016-08-16 2019-02-14 Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos.

Country Status (13)

Country Link
US (2) US10968252B2 (enExample)
EP (2) EP3950702A1 (enExample)
JP (3) JP7106523B2 (enExample)
KR (1) KR102465761B1 (enExample)
CN (1) CN109843906B (enExample)
AU (1) AU2017313042A1 (enExample)
BR (1) BR112019003013A2 (enExample)
CA (1) CA3034092A1 (enExample)
MX (2) MX2019001859A (enExample)
RU (2) RU2751506C2 (enExample)
SG (1) SG11201901220XA (enExample)
TW (1) TWI767930B (enExample)
WO (1) WO2018035116A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI767930B (zh) 2016-08-16 2022-06-21 美商健臻公司 處理包括重組治療性蛋白之流體的方法及其用途
SG11202003440SA (en) * 2017-11-16 2020-05-28 Chromacon Ag Method for monitoring, evaluating, and controlling a cyclic chromatographic purification process
TWI846694B (zh) * 2018-05-04 2024-07-01 美商健臻公司 具有過濾系統的灌注式生物反應器
MX2021010891A (es) 2019-03-11 2021-12-10 Genzyme Corp Filtracion tangencial de virus.
KR20210148274A (ko) * 2019-04-01 2021-12-07 베링거 인겔하임 인터내셔날 게엠베하 통합된 연속적인 재조합 단백질의 제조
AU2020253381A1 (en) 2019-04-03 2021-12-02 Genzyme Corporation Continuous production of recombinant proteins
WO2020258515A1 (zh) * 2019-06-28 2020-12-30 浙江大学 多柱连续流层析设计及分析的方法
TW202532844A (zh) * 2019-09-23 2025-08-16 美商健臻公司 用於測量生物樣品的分析物的多個產品品質屬性的方法
AU2020372397A1 (en) 2019-10-22 2022-06-09 Genzyme Corporation In-line product monitoring in integrated continuous bio-manufacturing
AU2021340897B2 (en) * 2020-09-14 2023-05-25 Enquyst Technologies Inc. Process technology for biological product manufacturing and downstream purification
US12458908B2 (en) * 2020-11-30 2025-11-04 PAK Biosolutions Inc. End-to-end continuous purification system
KR20240039642A (ko) * 2022-09-19 2024-03-27 주식회사 녹십자 신규 헤파란-n-설파타아제의 정제 방법
WO2024072963A1 (en) 2022-09-28 2024-04-04 Genzyme Corporation Systems and devices for producing biological products and methods of using the same
EP4397323A1 (de) * 2023-01-09 2024-07-10 Sartorius Stedim Biotech GmbH Verfahren zur inaktivierung von viren in einem fluid

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH692479A5 (de) * 1997-07-08 2002-07-15 Bucher Guyer Ag Querstrom-Filtrationsanlage sowie Verfahren zum Betrieb einer solchen Anlage.
GB9821342D0 (en) 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
US6296770B1 (en) * 1999-12-09 2001-10-02 Eastman Kodak Company Constant concentration at the UF membrane wall UF process control and apparatus
US6365395B1 (en) * 2000-11-03 2002-04-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
AU2002229545B2 (en) 2000-11-13 2007-08-30 Bayer Aktiengesellschaft Method of inactivating microorganisms in a fluid using ultraviolet radiation
JP4319979B2 (ja) * 2002-04-26 2009-08-26 ジェネンテック・インコーポレーテッド タンパク質の非アフィニティ精製
US20060051347A1 (en) * 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US7384549B2 (en) * 2005-12-29 2008-06-10 Spf Innovations, Llc Method and apparatus for the filtration of biological solutions
US20080017576A1 (en) * 2006-06-15 2008-01-24 Rensselaer Polytechnic Institute Global model for optimizing crossflow microfiltration and ultrafiltration processes
US20080207487A1 (en) * 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
US7988859B2 (en) 2009-02-05 2011-08-02 Chromatan Inc. Countercurrent tangential chromatography methods, systems, and apparatus
US20100237013A1 (en) * 2009-02-13 2010-09-23 Millipore Corporation Autonomous filter element
US8728479B2 (en) 2009-03-31 2014-05-20 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
EP2509873B1 (en) 2009-12-11 2019-03-20 Wyssmont Company Inc. Apparatus and method for continuous lyophilization
SI2914612T1 (sl) 2012-10-30 2019-03-29 F. Hoffmann-La Roche Ag Čiščenje polipeptidov z uporabo dvostopenjske tangencialne ultrafiltracije
JP6392245B2 (ja) * 2012-12-18 2018-09-19 ノバルティス アーゲー 遺伝子改変哺乳動物細胞における治療用タンパク質の産生
HK1219964A1 (zh) * 2013-03-08 2017-04-21 Genzyme Corporation 治疗性蛋白药物物质的整合连续制造
TWI767930B (zh) 2016-08-16 2022-06-21 美商健臻公司 處理包括重組治療性蛋白之流體的方法及其用途

Also Published As

Publication number Publication date
BR112019003013A2 (pt) 2019-05-14
RU2019107142A3 (enExample) 2020-12-17
EP3950702A1 (en) 2022-02-09
RU2021119421A (ru) 2021-07-13
MX2021015165A (es) 2022-01-18
EP3500589A1 (en) 2019-06-26
AU2017313042A1 (en) 2019-04-04
EP3500589B1 (en) 2022-05-04
TW201811816A (zh) 2018-04-01
RU2019107142A (ru) 2020-09-18
CN109843906B (zh) 2023-09-01
US10968252B2 (en) 2021-04-06
JP2019532916A (ja) 2019-11-14
US11884703B2 (en) 2024-01-30
WO2018035116A1 (en) 2018-02-22
TWI767930B (zh) 2022-06-21
RU2751506C2 (ru) 2021-07-14
SG11201901220XA (en) 2019-03-28
JP2024079790A (ja) 2024-06-11
KR102465761B1 (ko) 2022-11-09
CA3034092A1 (en) 2018-02-22
US20180051054A1 (en) 2018-02-22
JP7106523B2 (ja) 2022-07-26
CN109843906A (zh) 2019-06-04
US20210171572A1 (en) 2021-06-10
JP2022110128A (ja) 2022-07-28
KR20190046872A (ko) 2019-05-07

Similar Documents

Publication Publication Date Title
MX2021015165A (es) Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos.
ZA201906881B (en) Methods and system for high-throughput blood component collection
DE112017000667A5 (de) Auslassgraft sowie system umfassend eine blutpumpe und einen auslassgraft
EP3810219C0 (en) PERCUTANEOUS BLOOD PUMP AND INTRODUCER SYSTEM
EP3820198A4 (en) SECURITY PROTECTION SYSTEM, DEVICE AND METHOD
EP3471735A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
EP3565516A4 (en) INFUSION SYSTEM AND ITS COMPONENTS
EP3474934A4 (en) BREATHING PATIENT MASK WITH INTEGRATED MICROPHONE AND METHOD USING THE SAME FOR COMMUNICATION WITH THE PATIENT
MX2020001823A (es) Fabricacion continua integrada de principios activos proteinicos terapeuticos.
EP3704651A4 (en) PROCESS AND SYSTEM ENSURING INTEROPERABILITY BETWEEN ECOSYSTEMS WITH BLOCK CHAINS
EP3508232A4 (en) MEDICAL MATERIAL, MEDICAL SEPARATING MEMBRANE AND BLOOD CLEANER
EP3802359A4 (en) Smart medication dispensing system and method
EP3603690A4 (en) BLOOD SEPARATION PROCESS AND BLOOD SEPARATION FILTER
KR102001790B9 (ko) 인공지능 기반 혈류 구간 분류 방법 및 시스템
EP3490538A4 (en) PARTICLES FOR THE DELIVERY OF PROTEINS AND PEPTIDES
EP3703982A4 (en) AIRBAG SUCTION MODULES AND ASSOCIATED VALVE ARRANGEMENTS
IL272601A (en) Pharmaceutical compositions for the treatment of ophthalmic conditions
EP4073254C0 (en) EXTRACORPOREAL BLOOD TREATMENT SYSTEMS AND METHODS USING BATCH PROCESSING
EP3452155A4 (en) BREATH SUPPORT SYSTEM AND BLOWER FOR BREATH SUPPORT SYSTEM
EP3419498C0 (en) MEDICAL GAS DISTRIBUTION SYSTEM
PH12017502386B1 (en) Methods of purification and/or viral inactivation
IL276971A (en) In vitro device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof
EP3324954A4 (en) AMINONAPTHOCHINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING A UBIQUITINATION PROTEASOM SYSTEM FOR DISEASES
EP3947103A4 (en) MULTI-LEVEL DISTRIBUTION SYSTEM AND ASSOCIATED DEVICE
EA201892265A1 (ru) Способы лечения офтальмологических заболеваний